October 25, 2021
October 25, 2021 –
XipereTM (triamcinolone acetonide injectable suspension) has been approved by the U.S. FDA for suprachoroidal use to treat macular edema
October 25, 2021
September 25 –
Eli Lilly has recalled one lot of Glucagon® Emergency Kit for Low Blood Sugar (Glucagon for Injection, 1mg per vial; Diluent for Glucagon, 1mL syringe)
October 22, 2021
October 22, 2021 –
Oncopeptides will withdraw Pepaxto® (melphalan flufenamide) from the United States market after a post-marketing clinical trial raised safety concerns
October 22, 2021
October 22, 2021 –
Cyltezo® (adalimumab-adbm – Boehringer Ingelheim) has received U.S. FDA approval to reduce the signs and symptoms of moderately to severely
October 20, 2021
October 20, 2021 –
The U.S. FDA has amended the emergency use authorizations (EUAs) for COVID-19
vaccines to expand the use of booster shots in eligible individuals
October 20, 2021
October 20, 2021 –
Vimpat® (lacosamide – UCB, Inc.) has been approved to treat partial-onset seizures in patients who are at least one month old. This indication was previously
October 20, 2021
October 20, 2021 –
Dupixent® (dupilumab) can now be used to treat asthma in a wider age group, as the U.S. FDA has expanded its asthma indication to include children ages
October 19, 2021
October 19, 2021 –
Merck has recalled one lot of Cubicin® (daptomycin for injection) 500mg for intravenous (IV) infusion, following a customer complaint that a piece